Previous studies by Jelski et al revealed paradoxical elevation of class I alcohol dehydrogenase (ADH) activity in serum of stage IV breast cancer patients, despite overall reduction of ADH/aldehyde dehydrogenase activities in tumor tissue.[63,64] This suggests distinct regulatory mechanisms between localized and systemic metabolic adaptation. The gene discussed is AKR1A1; the disease is neoplasm.